A diferencia de otros tratamientos ya conocidos, como la semaglutida (Ozempic, Wegovy), la tirzepatida acta de forma dual sobre dos receptores hormonales incretnicos: el GLP-1 (peptdeo similar al glucagn tipo 1) y el GIP (polipptido insulinotrpico dependiente de glucosa)
* Assumes a potential 20% rebate and 25% member cost-sharing on the drug and identical GLP-1 utilization as previous year
5 By pairing medication with personalized nutrition and lasting behavior change, organizations can help members maintain progress while reducing reliance on lifelong medication
Please call us or fill in the form below and we will be delighted to help with your enquiry
It can help address complex challenges like insulin resistance, unstable energy, and hormonal imbalances more effectively than single-pathway therapies
The Natural Medicines database rates this combination as having insufficient reliable information to conclude harm, which is categorically different from identifying a danger signal